. 2014 Nov 7;15(11):20486–20499. doi: 10.3390/ijms151120486

Table 1.

Correlation between the clinicopathologic characteristics and miR-130b expression in HCC.

Characteristics		Total No. of Patients, n = 86	No. of Patients		p
Characteristics		Total No. of Patients, n = 86	miR-130b ^high	miR-130b ^low	p
Age (year)	<50	36	19	17	0.323
Age (year)	≥50	50	21	29	0.323
Sex	Male	65	28	37	0.261
Sex	Female	21	12	9	0.261
HBV	Absent	28	9	19	0.063
HBV	Present	58	31	27	0.063
Serum AFP level (ng/mL)	<400	32	14	18	0.693
Serum AFP level (ng/mL)	≥400	54	26	28	0.693
Tumor size (cm)	<5	32	16	16	0.618
Tumor size (cm)	≥5	54	24	30	0.618
No. of tumor nodules	1	68	28	40	0.054
No. of tumor nodules	≥2	18	12	6	0.054
Cirrhosis	Absent	36	13	23	0.101
Cirrhosis	Present	50	27	23	0.101
Venous infiltration	Absent	76	31	45	0.009 *
Venous infiltration	Present	10	9	1	0.009 *
Edmondson-Steiner grading	I + II	65	25	40	0.008 *
Edmondson-Steiner grading	III + IV	21	15	6	0.008 *
TNM tumor stage	I + II	66	22	44	<0.001 *
TNM tumor stage	III + IV	20	18	2	<0.001 *

HCC, hepatocellular carcinoma; HBV, hepatitis B virus; AFP, alpha-fetoprotein; TNM, tumor-node-metastasis; * Statistically significant.